跳至主要内容
临床试验/CTRI/2010/091/000141
CTRI/2010/091/000141已完成3 期

A Comparative, Randomized, Double Blind, Multicentric, Prospective Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Flutrimazole 1% cream Vs. Terbinafine Hydrochloride 1% cream in patients with Dermatomycoses.

Ajanta Pharma Ltd0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Clinical diagnosis of Dermatomycoses confirmed by laboratory evaluation (microscopic examination confirmed by a positive potassium hydroxide test).
  • 2. Written informed consent by patient.
  • 3. Patient willing to follow up.

排除标准

  • 1. Pregnant or nursing females.
  • 2. Patients with severe chronic diseases.
  • 3. Individuals who present a history of hypersensitivity to other antifungal imidazolic, or any of the components of the pharmaceutical form used.
  • 4. Patients who might have required concomitant medication with other antimycotics administered by another route.

研究者

相似试验